SG Americas Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Buy
53,548
+13,935
+35% +$60.2K ﹤0.01% 2576
2026
Q1
$153K Buy
39,613
+294
+0.7% +$1.21K ﹤0.01% 2766
2025
Q4
$164K Buy
39,319
+15,969
+68% +$61.8K ﹤0.01% 3012
2025
Q3
$77K Sell
23,350
-55,171
-70% -$156K ﹤0.01% 3130
2025
Q2
$112K Buy
78,521
+33,173
+73% +$47.1K ﹤0.01% 2585
2025
Q1
$68K Sell
45,348
-12,293
-21% -$19.4K ﹤0.01% 3163
2024
Q4
$65K Buy
57,641
+12,578
+28% +$10.7K ﹤0.01% 2857
2024
Q3
$43K Buy
45,063
+13,823
+44% +$17.4K ﹤0.01% 3278
2024
Q2
$49K Sell
31,240
-20,529
-40% -$29.8K ﹤0.01% 2675
2024
Q1
$75K Sell
51,769
-24,583
-32% -$35.3K ﹤0.01% 2636
2023
Q4
$102K Buy
76,352
+8,478
+12% +$9.96K ﹤0.01% 2752
2023
Q3
$96K Buy
+67,874
New +$96.2K ﹤0.01% 2805
2023
Q2
Sell
-52,354
Closed -$55K 2962
2023
Q1
$55K Buy
52,354
+17,028
+48% +$24.6K ﹤0.01% 3054
2022
Q4
$54K Sell
35,326
-24,633
-41% -$42.4K ﹤0.01% 2831
2022
Q3
$127K Sell
59,959
-5,530
-8% -$11.7K ﹤0.01% 2670
2022
Q2
$88K Sell
65,489
-24,333
-27% -$36.1K ﹤0.01% 3164
2022
Q1
$190K Buy
89,822
+64,372
+253% +$157K ﹤0.01% 2461
2021
Q4
$94K Sell
25,450
-42,319
-62% -$182K ﹤0.01% 3099
2021
Q3
$338K Buy
67,769
+54,699
+419% +$315K ﹤0.01% 2836
2021
Q2
$85K Sell
13,070
-8,810
-40% -$61.6K ﹤0.01% 2703
2021
Q1
$151K Buy
21,880
+3,624
+20% +$30.6K ﹤0.01% 2855
2020
Q4
$186K Sell
18,256
-10,401
-36% -$67.4K ﹤0.01% 2666
2020
Q3
$100K Sell
28,657
-8,035
-22% -$38.1K ﹤0.01% 2460
2020
Q2
$183K Sell
36,692
-12,071
-25% -$41.1K ﹤0.01% 2932
2020
Q1
$166K Buy
+48,763
New +$210K ﹤0.01% 2645
2019
Q4
Sell
-36,047
Closed -$206K 3401
2019
Q3
$206K Buy
36,047
+14,503
+67% +$98.5K ﹤0.01% 2338
2019
Q2
$165K Sell
21,544
-31,962
-60% -$172K ﹤0.01% 2534
2019
Q1
$281K Buy
53,506
+20,677
+63% +$143K ﹤0.01% 2322
2018
Q4
$215K Buy
32,829
+25,223
+332% +$283K ﹤0.01% 2347
2018
Q3
$131K Buy
+7,606
New +$113K ﹤0.01% 2757
2018
Q2
Sell
-25,396
Closed -$389K 3497
2018
Q1
$389K Buy
25,396
+11,836
+87% +$169K ﹤0.01% 2018
2017
Q4
$156K Buy
13,560
+6,251
+86% +$93.1K ﹤0.01% 2610
2017
Q3
$139K Buy
+7,309
New +$150K ﹤0.01% 2919
2017
Q2
Sell
-8,258
Closed -$164K 3422
2017
Q1
$164K Buy
+8,258
New +$184K ﹤0.01% 2592
2015
Q4
Sell
-10,595
Closed -$334K 2912
2015
Q3
$334K Buy
+10,595
New +$517K ﹤0.01% 1202
2014
Q3
Sell
-10,867
Closed -$261K 2788
2014
Q2
$261K Buy
+10,867
New +$220K ﹤0.01% 1908

Other funds holding PGEN

SG Americas Securities's PGEN Position: Q2 2026 in Review

SG Americas Securities increased its Precigen (PGEN) stake by 35% in Q2 2026, buying an estimated $60.2K and bringing the position to 53,548 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #2576.

SG Americas Securities first reported a position in PGEN in Q2 2014 and has held it in 36 quarters since. The position peaked at $389K in Q1 2018. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • SG Americas Securities held 53,548 shares of Precigen worth $305K as of Q2 2026.
  • SG Americas Securities bought 13,935 Precigen shares in Q2 2026, an estimated $60.2K.
  • Precigen made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2576 holding.
  • SG Americas Securities first reported a position in Precigen in Q2 2014 and has held it in 36 quarters since.
  • SG Americas Securities's Precigen position peaked at $389K in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.